Clinical efficacy of alprostadil combined with α-lipoic acid in the treatment of elderly patients with diabetic nephropathy

Affiliations

Hong Yan: Department of Pharmacy, The fifth Affiliated Hospital of Wenzhou Medical University, Lishui Central Hospital, LishuiZhejiang Province 323000, PR China
Peng Jianyun: Department of Nephrology, The sixth Affiliated Hospital of Wenzhou Medical University, People‘s Hospital of Lishui City, LishuiZhejiang Province 323000, PR China
Cai Xiaoping: Department of Respiratory, The sixth Affiliated Hospital of Wenzhou Medical University, People‘s Hospital, Lishui City, ZhejiangChina
Zhang Xiaoru: Department of Nephrology, The sixth Affiliated Hospital of Wenzhou Medical University, People‘s Hospital of Lishui City, LishuiZhejiang Province 323000, PR China
Liao Yifei: Department of Nephrology, The sixth Affiliated Hospital of Wenzhou Medical University, People‘s Hospital of Lishui City, LishuiZhejiang Province 323000, PR China
Lan Lejian: Department of Nephrology, The sixth Affiliated Hospital of Wenzhou Medical University, People‘s Hospital of Lishui City, LishuiZhejiang Province 323000, PR China

Abstract

To evaluate the effect and toxicity of alprostadil combined with thioctic acid injection in the treatment of patients with diabetic nephropathy (DN).